278 related articles for article (PubMed ID: 32547936)
21. Non-invasive screening of a microRNA-based dysregulation signature in oral cancer and oral potentially malignant disorders.
Yap T; Seers C; Koo K; Cheng L; Vella LJ; Hill AF; Reynolds E; Nastri A; Cirillo N; McCullough M
Oral Oncol; 2019 Sep; 96():113-120. PubMed ID: 31422202
[TBL] [Abstract][Full Text] [Related]
22. Expression of MiRNA-137 in oral squamous cell carcinoma and its clinical significance.
Sun C; Li J
J BUON; 2018; 23(1):167-172. PubMed ID: 29552778
[TBL] [Abstract][Full Text] [Related]
23. Emerging role of microRNAs in prostate cancer: implications for personalized medicine.
Gandellini P; Folini M; Zaffaroni N
Discov Med; 2010 Mar; 9(46):212-8. PubMed ID: 20350487
[TBL] [Abstract][Full Text] [Related]
24. MicroRNAs: new actors in the oral cancer scene.
Wu BH; Xiong XP; Jia J; Zhang WF
Oral Oncol; 2011 May; 47(5):314-9. PubMed ID: 21474366
[TBL] [Abstract][Full Text] [Related]
25. MiRNA s in oesophageal squamous cancer.
Chu Y; Zhu H; Lv L; Zhou Y; Huo J
Neth J Med; 2013 Mar; 71(2):69-75. PubMed ID: 23462054
[TBL] [Abstract][Full Text] [Related]
26. Downregulated miR329 and miR410 promote the proliferation and invasion of oral squamous cell carcinoma by targeting Wnt-7b.
Shiah SG; Hsiao JR; Chang WM; Chen YW; Jin YT; Wong TY; Huang JS; Tsai ST; Hsu YM; Chou ST; Yen YC; Jiang SS; Shieh YS; Chang IS; Hsiao M; Chang JY
Cancer Res; 2014 Dec; 74(24):7560-72. PubMed ID: 25351956
[TBL] [Abstract][Full Text] [Related]
27. CircDOCK1 suppresses cell apoptosis via inhibition of miR‑196a‑5p by targeting BIRC3 in OSCC.
Wang L; Wei Y; Yan Y; Wang H; Yang J; Zheng Z; Zha J; Bo P; Tang Y; Guo X; Chen W; Zhu X; Ge L
Oncol Rep; 2018 Mar; 39(3):951-966. PubMed ID: 29286141
[TBL] [Abstract][Full Text] [Related]
28. LncRNA HOTAIR promotes the invasion and metastasis of oral squamous cell carcinoma through metastasis-associated gene 2.
Tao D; Zhang Z; Liu X; Zhang Z; Fu Y; Zhang P; Yuan H; Liu L; Cheng J; Jiang H
Mol Carcinog; 2020 Apr; 59(4):353-364. PubMed ID: 31995261
[TBL] [Abstract][Full Text] [Related]
29. Salivary Biomarkers for Oral Squamous Cell Carcinoma Diagnosis and Follow-Up: Current Status and Perspectives.
Cristaldi M; Mauceri R; Di Fede O; Giuliana G; Campisi G; Panzarella V
Front Physiol; 2019; 10():1476. PubMed ID: 31920689
[TBL] [Abstract][Full Text] [Related]
30. Complex integrated analysis of lncRNAs-miRNAs-mRNAs in oral squamous cell carcinoma.
Li S; Chen X; Liu X; Yu Y; Pan H; Haak R; Schmidt J; Ziebolz D; Schmalz G
Oral Oncol; 2017 Oct; 73():1-9. PubMed ID: 28939059
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathways.
Fukumoto I; Hanazawa T; Kinoshita T; Kikkawa N; Koshizuka K; Goto Y; Nishikawa R; Chiyomaru T; Enokida H; Nakagawa M; Okamoto Y; Seki N
Br J Cancer; 2015 Mar; 112(5):891-900. PubMed ID: 25668004
[TBL] [Abstract][Full Text] [Related]
32. Predictive Prognostic Value of Tissue-Based MicroRNA Expression in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-analysis.
Troiano G; Mastrangelo F; Caponio VCA; Laino L; Cirillo N; Lo Muzio L
J Dent Res; 2018 Jul; 97(7):759-766. PubMed ID: 29533734
[TBL] [Abstract][Full Text] [Related]
33. miRNA Associated With Glucose Transporters in Oral Squamous Cell Carcinoma: A Systematic Review.
R P; Yuwanati M; Sekaran S; M S
Cureus; 2023 Sep; 15(9):e46057. PubMed ID: 37900425
[TBL] [Abstract][Full Text] [Related]
34. Identification of Candidate Biomarkers and Analysis of Prognostic Values in Oral Squamous Cell Carcinoma.
Huang GZ; Wu QQ; Zheng ZN; Shao TR; Lv XZ
Front Oncol; 2019; 9():1054. PubMed ID: 31681590
[No Abstract] [Full Text] [Related]
35. Salivary Micro-RNA and Oral Squamous Cell Carcinoma: A Systematic Review.
Menini M; De Giovanni E; Bagnasco F; Delucchi F; Pera F; Baldi D; Pesce P
J Pers Med; 2021 Feb; 11(2):. PubMed ID: 33557138
[TBL] [Abstract][Full Text] [Related]
36. Salivary exosomal miR-24-3p serves as a potential detective biomarker for oral squamous cell carcinoma screening.
He L; Ping F; Fan Z; Zhang C; Deng M; Cheng B; Xia J
Biomed Pharmacother; 2020 Jan; 121():109553. PubMed ID: 31704611
[TBL] [Abstract][Full Text] [Related]
37. A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma.
Zhou X; Wen W; Zhu J; Huang Z; Zhang L; Zhang H; Qi LW; Shan X; Wang T; Cheng W; Zhu D; Yin Y; Chen Y; Zhu W; Shu Y; Liu P
Oncotarget; 2017 May; 8(21):34468-34480. PubMed ID: 28380431
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of miRNA-expression and clinical tumour parameters in oral squamous cell carcinoma (OSCC).
Moratin J; Hartmann S; Brands R; Brisam M; Mutzbauer G; Scholz C; Seher A; Müller-Richter U; Kübler AC; Linz C
J Craniomaxillofac Surg; 2016 Jul; 44(7):876-81. PubMed ID: 27210505
[TBL] [Abstract][Full Text] [Related]
39. Micronome revealed miR-19a/b as key regulator of SOCS3 during cancer related inflammation of oral squamous cell carcinoma.
Christopher AF; Gupta M; Bansal P
Gene; 2016 Dec; 594(1):30-40. PubMed ID: 27581787
[TBL] [Abstract][Full Text] [Related]
40. Profiling MicroRNA Markers in Plasma: Looking into Better Approaches and Recommendations.
Matin F; Batra J
Methods Mol Biol; 2019; 2054():93-103. PubMed ID: 31482449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
